ECARX Says Ending US$ 100 Million Convertible Note Option Limits Further Shareholder Dilution

ECARX terminated an investor's right to purchase up to US$ 100 million of additional convertible notes under an October 12, 2026 agreement. The investor will receive a one-time cash fee of US$ 10 million by October 26, 2026; no further notes will be issued. CFO Dylan Jeng described the termination as a strategic decision to limit shareholder dilution and simplify the capital structure. Jeng said funding secured from institutional noteholders and banking partners makes the one-time cost beneficial to shareholders over the long term. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ECARDX Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-065943), on October 15, 2026, and is solely responsible for the information contained therein. (C)